CDX2 as a Predictive Biomarker Involved in Immunotherapy Response Suppresses Metastasis through EMT in Colorectal Cancer

BACKGROUND: Studies have confirmed that Caudal Type Homeobox 2 (CDX2) plays a tumor suppressor role in colorectal cancer (CRC) and as a prognostic and predictive marker for colorectal cancer. The epithelial to mesenchymal transition (EMT) is a transdifferentiation process, providing migratory and in...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Yun-shuai, Kou, Yu, Zhu, Ren-tao, Han, Bao-wei, Li, Chao-hui, Wang, Huang-jian, Wu, Hui-bin, Xia, Tian-ming, Che, Xiang-ming
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9582897/
https://www.ncbi.nlm.nih.gov/pubmed/36277982
http://dx.doi.org/10.1155/2022/9025668

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9582897/
https://www.ncbi.nlm.nih.gov/pubmed/36277982
http://dx.doi.org/10.1155/2022/9025668

Ejemplares similares